AIIMS to develop cheaper cancer drugs with French

Image
Press Trust of India New Delhi
Last Updated : Nov 19 2015 | 7:02 PM IST
AIIMS in collaboration with France-based FAM-Medical Academy Foundation and the French Embassy in India have decided to develop cheaper cancer and cardiovascular drugs.
Also, an exchange programme for researchers of both the countries to learn from each other in the fields of infection and neurological diseases will be initiated.
"France and India share a long tradition of cooperation in sciences and technology based on more than 60 years of history. The exchange research programme will help in finding the possible advanced treatments in the field of cardiovascular and neurological treatment," said Jean Marie, President of FAM, addressing media.
"This conclave has given us an opportunity to gain an insight into the medical development and innovations which shall prove to be mutually beneficial," said AIIMS Director M C Mishra.
The two countries have jointly developed a new anti-fertility medicine which is likely to be sold at a cheaper rate in the market in comparison to other infertility correction methods such as IVF.
However, as per AIIMS, the medicine is currently in trial and will take a year at least to be available in the market.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 19 2015 | 7:02 PM IST

Next Story